Title: Targeting the adipose vasculature for treatment of metabolic disease
Speaker: Prof. Yihai Cao, Karolinska Institutet, Stockholm, Sweden
Time: 17:00, 2 September 2022 (UTC/GMT +8, Beijing Time)
Host: Prof. Xing-Jie Liang & Prof. Bingyang Shi
Yihai Cao is a professor at the Karolinska Institutet, Stockholm, Sweden. He is a member of Chinese Academy of Engineering, Academy of Europe, European Academy of Sciences and Arts, National Academy of Inventors (US), and American Institute of Medicine and Biological Engineering. Yihai Cao received his medical training from the Shandong Medical School and his Ph.D. from the Karolinska Institute. He received his postdoctoral training in Dr. Judah Folkman’s laboratory at the Harvard Medical School. Cao’s laboratory has focused their interests on studying angiogenesis in tumor growth, metastasis, and non-malignant diseases. Through mechanistic studies, he aims to define novel therapeutic targets and resolve clinically unmet demands of antiangiogenic cancer therapy by proposing new concepts and paradigms. His research interests include molecular mechanisms of pathological angiogenesis contributing to obesity, metabolic diseases, diabetic complications, cancer, metastasis, and cardiovascular diseases, with emphasis on clinical relevance and translational research. He received an honorary medical doctor degree (M.D.) from Copenhagen University, Denmark in 2006. He is a guest professor at the Linköping University, Sweden; a guest professor at the Leicester University, UK; an honorary professor at the Copenhagen University, Denmark; and an honorary a professorship at the Shinshu University Japan. He received the Fernström research prize in 2004. He also received the Axel Hirsch Prize in medicine 2014. In 2010, Dr. Cao received a distinguished professor award at the Karolinska Institutet. He was ranked as an outstanding scientist by international experts during the Karolinska Institutet quality assessment in 2010. Dr. Cao received an ERC-advanced research grant award and the distinguished NOVO Nordisk-advanced grant award. His scientific articles have been cited for more than 42 900 times, h-index = 106.
Click here to attend the Webinar: Professor Yihai Cao, or scan the QR code below:
